35593471|t|Positive allosteric regulation of PAC1-R up-regulates PAC1-R and its specific ligand PACAP.
35593471|a|PAC1-R is a recognized preferential receptor for the neuropeptide of pituitary adenylate cyclase-activating polypeptide (PACAP), which mediates neuroprotective and nerve regenerative activities of PACAP. In this study, we found that in both PAC1R-CHO cells with high expression of PAC1R-eGFP and retinal ganglion cells (RGC-5) with the natural expression of PAC1-R, oligo-peptide PACAP(28-38) and the positively charged arginine-rich penetrating peptide TAT, as positive allosteric modulators of PAC1-R, significantly trigger the nuclear translocation of PAC1-R. The chromatin immunoprecipitation (ChIP)-PCR results show that the nuclear translocated PAC1-R binds with the promoter regions of PAC1-R and its specific ligand PACAP. The up-regulated promoter activities of PAC1-R and PACAP induced by PACAP(28-38) or TAT are positively correlative with the increase of the expression levels of PAC1-R and PACAP. Moreover, the nuclear translocation of PAC1-R induced by PACAP(28-38) or TAT is significantly inhibited by the mutation of PAC1-R on Cys25 and the palmitoylation inhibitor 2-bromopalmitate. Meanwhile, the increase in both PAC1-R and PACAP levels and the neuroprotective activities of PACAP(28-38) and TAT in MPP-induced cell model of Parkinson ' s disease are synchronously inhibited by 2-bromopalmitate, which are positively correlated with the nuclear translocation of PAC1-R induced by PACAP(28-38) or TAT. Bioinformatics analysis and motif enrichment analysis following ChIP-sequencing show that the transcription factors including SP1, Zic2, GATA1, REST and YY1 may be recruited by nuclear PAC1-R and involved in regulating the promoter activities of PAC1-R and PACAP. ChIP-sequencing and related bioinformatics analysis show that the downstream target genes regulated by the nuclear PAC1-R are mostly involved in the process of cellular stress and related to neuroprotection, neuronal genesis and development.
35593471	34	40	PAC1-R	Gene	117
35593471	54	60	PAC1-R	Gene	117
35593471	85	90	PACAP	Gene	116
35593471	92	98	PAC1-R	Gene	117
35593471	213	218	PACAP	Gene	116
35593471	289	294	PACAP	Gene	116
35593471	333	338	PAC1R	Gene	117
35593471	339	342	CHO	CellLine	CVCL:0213
35593471	373	378	PAC1R	Gene	117
35593471	412	417	RGC-5	CellLine	CVCL:4059
35593471	450	456	PAC1-R	Gene	117
35593471	472	477	PACAP	Gene	116
35593471	588	594	PAC1-R	Gene	117
35593471	647	654	PAC1-R.	Gene	117
35593471	743	749	PAC1-R	Gene	117
35593471	785	791	PAC1-R	Gene	117
35593471	816	821	PACAP	Gene	116
35593471	863	869	PAC1-R	Gene	117
35593471	874	879	PACAP	Gene	116
35593471	891	896	PACAP	Gene	116
35593471	984	990	PAC1-R	Gene	117
35593471	995	1000	PACAP	Gene	116
35593471	1041	1047	PAC1-R	Gene	117
35593471	1059	1064	PACAP	Gene	116
35593471	1125	1131	PAC1-R	Gene	117
35593471	1174	1190	2-bromopalmitate	Chemical	MESH:C022776
35593471	1224	1230	PAC1-R	Gene	117
35593471	1235	1240	PACAP	Gene	116
35593471	1286	1291	PACAP	Gene	116
35593471	1336	1357	Parkinson ' s disease	Disease	MESH:D010300
35593471	1389	1405	2-bromopalmitate	Chemical	MESH:C022776
35593471	1473	1479	PAC1-R	Gene	117
35593471	1491	1496	PACAP	Gene	116
35593471	1643	1647	Zic2	Gene	7546
35593471	1649	1654	GATA1	Gene	2623
35593471	1665	1668	YY1	Gene	7528
35593471	1697	1703	PAC1-R	Gene	117
35593471	1758	1764	PAC1-R	Gene	117
35593471	1769	1774	PACAP	Gene	116
35593471	1891	1897	PAC1-R	Gene	117
35593471	Association	117	2623
35593471	Negative_Correlation	MESH:C022776	116
35593471	Association	MESH:D010300	117
35593471	Negative_Correlation	MESH:C022776	117
35593471	Association	117	7528
35593471	Bind	117	7546
35593471	Negative_Correlation	MESH:C022776	MESH:D010300
35593471	Association	MESH:D010300	116
35593471	Positive_Correlation	116	117

